These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 25227162
1. 1,2-Diaryl-2-hydroxyiminoethanones as dual COX-1 and β-amyloid aggregation inhibitors: biological evaluation and in silico study. Irannejad H, Unsal Tan O, Ozadali K, Dadashpour S, Tuylu Kucukkilinc T, Ahangar N, Ahmadnejad M, Emami S. Chem Biol Drug Des; 2015 Apr; 85(4):494-503. PubMed ID: 25227162 [Abstract] [Full Text] [Related]
2. Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors. Dadashpour S, Tuylu Kucukkilinc T, Unsal Tan O, Ozadali K, Irannejad H, Emami S. Arch Pharm (Weinheim); 2015 Mar; 348(3):179-87. PubMed ID: 25690564 [Abstract] [Full Text] [Related]
5. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif. Kino R, Araya T, Arai T, Sohma Y, Kanai M. Bioorg Med Chem Lett; 2015 Aug 01; 25(15):2972-5. PubMed ID: 26045033 [Abstract] [Full Text] [Related]
7. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. Francioso A, Punzi P, Boffi A, Lori C, Martire S, Giordano C, D'Erme M, Mosca L. Bioorg Med Chem; 2015 Apr 15; 23(8):1671-83. PubMed ID: 25769517 [Abstract] [Full Text] [Related]
8. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents. Abdelazeem AH, Abdelatef SA, El-Saadi MT, Omar HA, Khan SI, McCurdy CR, El-Moghazy SM. Eur J Pharm Sci; 2014 Oct 01; 62():197-211. PubMed ID: 24907682 [Abstract] [Full Text] [Related]
10. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties. Guzior N, Bajda M, Skrok M, Kurpiewska K, Lewiński K, Brus B, Pišlar A, Kos J, Gobec S, Malawska B. Eur J Med Chem; 2015 Mar 06; 92():738-49. PubMed ID: 25621991 [Abstract] [Full Text] [Related]
11. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents. Manivannan E, Chaturvedi SC. Bioorg Med Chem; 2011 Aug 01; 19(15):4520-8. PubMed ID: 21724403 [Abstract] [Full Text] [Related]
12. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy. Cheng S, Zheng W, Gong P, Zhou Q, Xie Q, Yu L, Zhang P, Chen L, Li J, Chen J, Chen H, Chen H. Bioorg Med Chem; 2015 Jul 01; 23(13):3110-8. PubMed ID: 26025073 [Abstract] [Full Text] [Related]
14. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors. Shahapurkar S, Pandya T, Kawathekar N, Chaturvedi SC. Eur J Med Chem; 2004 Apr 01; 39(4):383-8. PubMed ID: 15072847 [Abstract] [Full Text] [Related]
15. Hexahydropyrrolo[2,3-b]indole Compounds as Potential Therapeutics for Alzheimer's Disease. Doens D, Valdés-Tresanco ME, Vasquez V, Carreira MB, De La Guardia Y, Stephens DE, Nguyen VD, Nguyen VT, Gu J, Hegde ML, Larionov OV, Valiente PA, Lleonart R, Fernández PL. ACS Chem Neurosci; 2019 Oct 16; 10(10):4250-4263. PubMed ID: 31545596 [Abstract] [Full Text] [Related]
16. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease. Lan JS, Xie SS, Li SY, Pan LF, Wang XB, Kong LY. Bioorg Med Chem; 2014 Nov 01; 22(21):6089-104. PubMed ID: 25282654 [Abstract] [Full Text] [Related]